Himadri Speciality Q2 FY27 results on Oct 16, 2026

What has been announced

Himadri Speciality Chemical Ltd (HSCL) has informed exchanges that its Board of Directors will meet on Friday, 16 October 2026. The agenda includes approving and taking on record the unaudited standalone and consolidated financial results for the quarter and half-year ended 30 September 2026. The disclosure was made under SEBI (LODR) Regulations, 2015, through a board meeting intimation.

The company has also flagged that the trading window for insiders will be reopened after the financial results are disclosed. Such trading window closures and re-openings are part of standard compliance around unpublished price sensitive information. For investors, the key takeaway is the formal confirmation of the upcoming results date.

Regulation 30 disclosure and newspaper publication

Alongside the board meeting update, HSCL also made an announcement under Regulation 30 (LODR) related to newspaper publication. The publication pertains to the company’s unaudited financial results for the quarter ended 30 June 2026. This is a routine requirement where companies publish results in newspapers and then intimate exchanges.

While the newspaper publication does not change the underlying financial numbers, it is one of the compliance steps that typically follows board approval of quarterly results. For market participants tracking the timeline, this helps connect the sequence of events around Q1 FY27 reporting.

Results calendar: last and upcoming earnings dates

HSCL’s disclosures and market data points indicate the last earnings date as 15 July 2026 for Q1 FY26-27. The upcoming earnings date is indicated as 16 October 2026 for Q2 FY26-27. The 16 October meeting is therefore positioned as the forum where the board will approve Q2 FY27 (July to September 2026) results and half-year figures.

This matters because half-year reporting can offer a clearer view of how the year is shaping up compared with a single quarter. It also tends to carry additional commentary around operations and outlook, although that will only be known once the company releases the results.

What is known from Q1 FY27 performance

Market summaries in the provided data point to strong year-on-year growth in Q1 FY26-27. Revenue for the quarter ended June 2026 is reported at ₹1,431.88 crore, while another summary rounds it to ₹1,432 crore. Net profit for the quarter is cited at ₹229.52 crore, while a separate line references ₹228 crore, indicating rounding differences across sources.

The company’s Q1 FY27 EPS is reported at ₹4.55, up from ₹3.68 in 1Q 2026. On growth rates, the Q1 update notes revenue growth of about 28% year-on-year and net profit growth of about 27% year-on-year. Sequentially, net profit is also stated to have risen 14.31% versus the prior quarter.

Recap of Q2 FY26 numbers mentioned in recent updates

The provided material also contains references to “Second quarter 2026” performance, which is presented as a separate historical comparison point. One summary lists Q2 FY26 EPS at ₹3.58 (up from ₹2.74 in 2Q 2025) and revenue at ₹1,070 crore (down about 5.8% from 2Q 2025). It also lists net income at ₹177 crore (up 31% from 2Q 2025).

Separately, another line states HSCL reported Q2 FY26 net profit of ₹186.85 crore, up 39%, with revenue declining 5.70% to ₹1,070.41 crore. Since both figures appear in the provided text, readers should treat them as two reported snapshots from different summaries, and rely on the company’s official financial statements for the final reconciled figure set.

Dividend track record highlighted in the updates

Corporate action references in the material include two dividend data points. The company’s AGM held on 12 June 2025 approved a dividend of ₹0.60 per share for the financial year ended 31 March 2025. Another entry notes that in the quarter ending March 2026, HSCL declared a dividend of ₹0.80 per share on 23 April 2026, with a stated dividend yield of 0.12%.

These disclosures provide context on shareholder distributions, but they do not indicate any new dividend decision linked to the 16 October 2026 board meeting agenda in the provided information.

Strategic context: battery materials expansion and anode plant

Beyond quarterly numbers, the text references HSCL’s push into battery materials. One update notes plans for a 200,000 MTPA Lithium Iron Phosphate (LFP) Cathode Active Material facility and a 150,000 TPA anode project. Another line states that Himadri has launched India’s first anode material plant and is targeting exports to the US and Europe starting Q3 FY27.

These initiatives are relevant because they can influence revenue mix, capex needs, and execution timelines. However, the upcoming 16 October 2026 board meeting notice itself is focused on approving and recording the unaudited financial results, not on project approvals.

What investors will watch on 16 October

The 16 October 2026 board meeting is expected to result in the release of unaudited standalone and consolidated results for Q2 FY27 and the half-year ended 30 September 2026. Investors typically compare these numbers with Q1 FY27 (June quarter) and with the year-ago quarter to assess whether growth trends are sustaining.

Given that the company has reported strong Q1 FY27 growth in both revenue and profit, the market will likely focus on whether margins and profitability remain consistent into the September quarter. Another key point to watch will be the company’s compliance update on the trading window re-opening after results disclosure.

Key numbers and dates at a glance

Why this update matters

A confirmed board meeting date gives the market a clear marker for when audited or unaudited financial information will be released. For HSCL, the October meeting is also tied to half-year reporting, which can sharpen visibility on how FY27 is progressing after a strong June quarter.

The additional context on battery materials expansion indicates that operational and investment priorities are evolving. But the immediate catalyst remains the formal results approval and disclosure process on 16 October 2026, after which the trading window is expected to reopen as per the company’s stated compliance step.

Conclusion

Himadri Speciality Chemical has set 16 October 2026 as the board meeting date to approve and take on record unaudited Q2 FY27 and H1 FY27 standalone and consolidated results. The company has also reiterated standard compliance actions, including reopening the trading window after results disclosure. The next definitive update will be the financial results release following the board’s consideration on the scheduled date.